(Q62129133)

1

0 references

author name string

Robert De Rose

1

0 references

Socheata Chea

2

0 references

C Jane Dale

3

0 references

Jeanette Reece

4

0 references

Caroline S Fernandez

5

0 references

Kim M Wilson

6

0 references

Scott Thomson

7

0 references

Ian A Ramshaw

8

0 references

Barbara E H Coupar

9

0 references

David B Boyle

10

0 references

Mark T Sullivan

11

0 references

Stephen J Kent

12

0 references

C. Jane Dale

3

0 references

Caroline S. Fernandez

5

0 references

Kim M. Wilson

6

0 references

Ian A. Ramshaw

8

0 references

Barbara E.H. Coupar

9

0 references

David B. Boyle

10

0 references

Mark T. Sullivan

11

0 references

Stephen J. Kent

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

12

0 references

language of work or name

English

0 references

publication date

14 March 2005

0 references

March 2005

0 references

published in

Vaccine

0 references

volume

23

0 references

issue

16

0 references

page(s)

1949-56

0 references

1949-1956

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Vpr Is Preferentially Targeted by CTL During HIV-1 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Immune control of HIV-1 after early treatment of acute infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

HIV preferentially infects HIV-specific CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

HIV T cell vaccines, the importance of clades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Virus-specific CD8+ T-cell memory determined by clonal burst size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012

Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.012